Paraneoplastic Myeloneuropathies
Neurol 96:e632-e639, Shah, S.,et al, 2021
Clinical Features of Trousseau Syndrome with Cerebral Infarction as the Initial Manifestation
Neurologist 25:117-121, Ren, R.,et al, 2020
Sensory Ganglionopathy
NEJM 383:1657-1662, Amato, A.A. & Ropper, A.H., 2020
Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies
Neurol 92:663-674, Johansen, A.,et al, 2019
The critical role of histopathology in diagnosing cancer-associated necrotizing CNS vasculitis
Neurol 90:808-811, Sheehan, J.,et al, 2018
Fat Embolism Syndrome Secondary to Bone Marrow Necrosis in Patients with Hemoglobinopathies
SMJ 109:549-553, Gangaraju, R.,et al, 2016
DWI Lesion Patterns in Cancer-Related Stroke-Specifying the Phenotype
Cerebrovasc Dis Extra 5:139-145, Schwarzbach, C.J.,et al, 2015
The Diagnosis and Treatment of Limbic Encephalitis
Acta Neurol Scand 126:365-375, Asztely, F. & Kumliem, E., 2012
Diagnostic Evaluation of Patients with a Brain Mass as the Presenting Manifestation of Cancer
Neurol 65:908-911, Mavrakis,A.N.,et al, 2005
Recommended Diagnostic Criteria for Paraneoplastic Neurological Syndromes
JNNP 75:1135-1140,1090, Graus,F.,et al, 2004
Spinal Epidural Metastasis as the Initial Manifestation of Malignancy:Clinical Features and Diagnostic Approach
Neurol 49:452-456, Schiff,D.,et al, 1997
Mitochondrial DNA and Disease
NEJM 333:638-644, Johns,D.R., 1995
Clinicopath Conference
Progressive Multifocal Leukoencephalopathy & Malignant Thymoma, with Metastases to Pleura, Case 1-19, 7, NE6:35-42,1987., 1987
Neurotoxicity of Commonly Used Antineoplastic Agents
NEJM 291:75, 1271974., Weiss,H.,et al, 1974
Infiltration of the Leptomeninges by Systemic Cancer:a Clinical & Pathologic Study
Arch Neurol 30:122, Olson,M.E.,et al, 1974